ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2019. The put-call ratio across all filers is 3.61 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | +50.0% | 8,171 | +32.4% | 0.00% | – |
| Q3 2019 | $4,000 | -50.0% | 6,171 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -11.1% | 6,171 | +48.0% | 0.00% | – |
| Q1 2019 | $9,000 | 0.0% | 4,171 | 0.0% | 0.00% | – |
| Q4 2018 | $9,000 | -40.0% | 4,171 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +66.7% | 4,171 | +61.8% | 0.00% | – |
| Q2 2018 | $9,000 | 0.0% | 2,578 | 0.0% | 0.00% | – |
| Q1 2018 | $9,000 | +350.0% | 2,578 | +533.4% | 0.00% | – |
| Q4 2017 | $2,000 | 0.0% | 407 | 0.0% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 407 | +25.6% | 0.00% | – |
| Q2 2017 | $2,000 | +100.0% | 324 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 324 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 324 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BARD ASSOCIATES INC | 124,300 | $87,000 | 0.04% |
| Hayden Royal, LLC | 16,000 | $12,272,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $16,000 | 0.01% |
| Founders Capital Management | 8,000 | $6,000 | 0.01% |
| Cable Hill Partners, LLC | 20,000 | $14,000 | 0.00% |
| Jacobi Capital Management LLC | 25,000 | $18,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $15,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 37,520 | $27,000 | 0.00% |
| Firestone Capital Management | 5,200 | $4,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $7,000 | 0.00% |